Has Oded Goren, MD received payments from drug or device companies?

Yes. Drug and device makers reported $448,238 in general payments to Oded Goren, MD across 408 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Oded Goren, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Oded Goren, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Oded Goren, MD

Neurological Surgery · Danville, PANPI 1003299629

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Microvention, Inc. accounts for 72.4% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $168,769, more than ten times the $551 reported in 2019. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$448,238in general payments, 2019–2025

Across 408 payments — averaging $1098.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Microvention, Inc.$325K
Stryker$76K
Route 92 Medical, Inc.$38K
Rapid Medical Ltd$9K
Penumbra, Inc.$260
Medtronic$233
plus $375 from 4 others

$60,283in research payments, 2019–2025

Across 46 payments — averaging $1310.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Microvention, Inc.$40K
Penumbra, Inc.$20K

What the payments were for

Consulting fees$229,65751%
Speaking & faculty fees$169,43038%
Travel & lodging$41,3739%
Food & beverage$7,7782%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Microvention, Inc.	276	$324,531
Stryker	93	$75,814
Route 92 Medical, Inc.	10	$38,156
Rapid Medical Ltd	15	$8,869
Penumbra, Inc.	2	$260
Medtronic	3	$233
Johnson & Johnson	4	$158
Imperative Care, Inc	3	$145
Silk Road Medical, Inc.	1	$52
Contego Medical, Inc	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WEB Aneurysm Embolization System$260,857
STENT$90,924
8F Base Camp Sheath System$14,215
TARGET$11,885
TIGERTRIEVER 17 REVASCULARIZATION DEVICE$8,351
COMANECI 17$8,351
SURPASS EVOLVE$7,975
SOFIA 6F-131CM STR$5,741
088 Access System$4,000
SALVATION$3,025
TREVO$2,425
TRANSFORM$2,260
LVIS JUNIOR$1,847
FLOCONTROL$1,706
EVOLVE PROLINE$1,650
N/A$1,400
T7$1,375
AXS INFINITY LS$1,375
EVOLVE$1,344
AXS VECTA 71$1,150

How this compares

$448,238 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$80,448

Medicare patients

115

Services billed

394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	17	$236

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Danville

Sanjay KonakondlaDanville$389K
Clemens SchirmerDanville$218K
Steven TomsDanville$53K
Amir DehdashtiDanville$47K
Amer SamdaniPhiladelphia$4.4M
Steven FalowskiFountain Hill$3M
Adam KanterPittsburgh$2.6M
David OkonkwoPittsburgh$2.3M
Brian JankowitzPhiladelphia$823K
Gaurav JainWynnewood$599K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →